Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2007
11/22/2007CA2651660A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/21/2007EP1857457A2 Benzimidazole derivative and its use as AII receptor antagonist
11/21/2007EP1857456A1 Process for producing compound with anti-hcv potency and intermediate for use therein
11/21/2007EP1857108A1 Preventive or therapeutic agent for herpesvirus-related disease
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856114A1 Benzisoxazole derivatives
11/21/2007EP1856113A1 Chiral bisoxazoline catalysts
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
11/21/2007EP1856098A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856097A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856082A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
11/21/2007EP1856062A1 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine mediated diseases
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
11/21/2007EP1855679A2 Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
11/21/2007EP1855676A1 Tetracyclic amino and carboxamido compounds and methods of use thereof
11/21/2007EP1855670A2 Benzazole potentiators of metabotropic glutamate receptors
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1197226B1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
11/21/2007CN101076529A Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101076334A Benzoureas having anti-diabetic activity
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN100349874C Novel compounds
11/20/2007US7297797 5-(2,6-difluorophenyl)-2-[4'-(5-ethoxy-2-thienyl)-1,1'-biphenyl-4-yl]-3,4-dihydro-2H-pyrrole; pesticide
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297714 Inhibitors of cathepsin S
11/20/2007US7297699 Piperazine and piperidine compounds
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007131179A1 Factor xa inhibitors
11/15/2007WO2007130823A2 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor
11/15/2007WO2007130822A2 Mglur5 modulators iii
11/15/2007WO2007130821A2 Mglur5 modulators ii
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129745A1 Heteroarylamide lower carboxylic acid derivative
11/15/2007WO2007128492A1 Novel pharmaceutical compositions
11/15/2007WO2007128410A1 Insecticidal compounds
11/15/2007WO2007128086A2 Novel viral replication inhibitor
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
11/15/2007WO2007099323A3 Quinoline derivatives
11/15/2007WO2007078523A3 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007070600A3 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
11/15/2007WO2007067416A3 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
11/15/2007WO2007061696A3 Spirolactam bicyclic cgrp receptor antagonists
11/15/2007WO2004032856A3 Compounds
11/15/2007US20070265451 Process for the preparation of oxazolidinones and method of use thereof
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265442 Process for {3-[2(R)-[(1R)-1-[3,5-Bis (Trifluoromethyl) Phenyl]Ethoxy]-3(S)-(4-Fluorophenyl) Morpholin-4-Yl}-5-Oxo-4,5-Dihydro-[1,2,4]-Triazol-1-Yl}Phosphonic Acid
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265308 5-[5-(2-chloro-4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-4-yl]-1-(2,6-dichlorophenyl)pyridin-2(1H)-one; p38 MAP kinase inhibitory activity; inflammatory, respiratory , circulatory and central nervous diseases; rheumatoid arthritis
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265289 2-Aminopyrimidine Derivative
11/15/2007US20070265266 Active Agents Combination Exhibiting Insecticidal and Acaricide Properties
11/15/2007US20070265264 Thia-tetraazaacenaphthylene kinase inhibitors
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265261 Dpp-IV Inhibitors
11/15/2007US20070265260 Quinazoline derivatives
11/15/2007US20070265259 Proline Derivatives
11/15/2007US20070265257 Morpholine Compound
11/15/2007US20070265256 Phosphodiesterase 10 inhibitors
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070264217 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
11/15/2007DE102006047618B3 Preparing bisbenzoxazole compound bonded together over a conjugated double bond system, useful e.g. as dye, comprises reacting o-aminophenol with dicarboxylic acid to form ammonium salt, which reacts with solvent, under microwave radiation
11/15/2007DE102006021878A1 Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Phenylamino-benzoxazole substituted carboxylic acids, process for their preparation and their use as medicaments
11/15/2007CA2654540A1 Histone deacetylase and tubulin deacetylase inhibitors
11/15/2007CA2651303A1 Factor xa inhibitors
11/15/2007CA2650114A1 Mglur5 modulators i
11/15/2007CA2649882A1 Novel pharmaceutical compositions
11/15/2007CA2649813A1 A system for wireless transmission of measurement results intended to be used in a coupling device and a use of the system in a vehicle
11/14/2007EP1854792A1 1-(2h)-isoquinolone derivative
11/14/2007EP1853597A1 Benzoxazole carboxamides for treating cinv and ibs-d
11/14/2007EP1853596A1 Novel, long-acting betamimetics for treating respiratory diseases
11/14/2007EP1853595A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics
11/14/2007EP1853587A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853269A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007EP1668003B1 Benzisoxazoles
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007EP1578745B1 BENZOFURAN DERIVATivES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF
11/14/2007EP1483262B1 Coumarines useful as biomarkers
11/14/2007CN101072775A Novel mch receptor antagonists
11/14/2007CN101072772A 凝血酶受体拮抗剂 Thrombin receptor antagonists
11/14/2007CN101072755A Pyridyl inhibitors of hedgehog signalling
11/14/2007CN101072560A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072559A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072558A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070308A Isoxazoline derivative and its use
11/14/2007CN101070304A Quinoline derivatives and their use as mycrobacterial inhibitors
11/14/2007CN100348597C Process for synthesizing 5,5' bit connected 1,1'-diphenyl kind axle chirality ligand
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 647